John McCamant Scans Under the Radar for Promising BiotechsInvestorIdeas.com (press release)Vice president of sales Michael Crum arrived in January after 13 years at Genentech ( Roche Holding AG (RHHBY:OTCQX)), cross-trained in selling cancer treatments…
Medical Daily |
Newly identified antibodies effectively treat Alzheimer’s-like disease in mice
Science Codex Alzheimer’s disease is characterized by the accumulation of particular toxic proteins in the brain that are believed to underlie the cognitive decline in patients. A new study conducted in mice suggests that newly identified antibody treatments can … Antibodies Could Halt Alzheimer’s And Dementia Onset, Improve Cognitive …Medical Daily |
|
Research and Markets: Global Monoclonal Antibodies Pipeline Capsule – 2013 …
Fort Mills Times The latest report ‘Global Monoclonal Antibodies Pipeline Capsule – 2013′ provides up-to-date information on key Research and Development activities (R&D) in the global monoclonal antibodies market. It covers active monoclonal antibodies pipeline … |
Medscape |
Boxed warning for HBV risk added to Rituxan, Arzerra
Clinical Advisor The FDA has announced that the anti-CD20-directed monoclonal antibodies rituximab (Rituxan) and ofatumumab (Arzerra) will carry a boxed warning for immunosupression-related reactivation of hepatitis B virus (HBV) in a drug safety communication. Boxed Warning on HBV Reactivation for Blood Cancer DrugsMedscape FDA updates ‘box warning’ for Arzerra and Rituxan to include Hepatitis B …The Global Dispatch Boxed warning for potential HBV reactivation added to Arzerra, Rituxan labelingHealio Pharmaceutical Processing all 5 news articles » |
|
Boxed warning for potential HBV reactivation added to Arzerra, Rituxan labeling
Healio Rituxan (rituximab, Genentech) is a therapy for CLL, non-Hodgkin’s lymphoma and conditions that include microscopic polyangiitis, granulomatosis with polyangiitis and rheumatoid arthritis. These drugs, along with other CD20-directed cytolytic … |
MedscapeBoxed Warning on HBV Reactivation for Blood Cancer DrugsMedscapeA boxed warning about the risk for reactivation of hepatitis B virus (HBV) infection in patients who once had the virus has been added to the product labeling for 2 drugs used in t…
Telegraph.co.ukShark antibodies may aid breast cancer fightTelegraph.co.ukIt is thought that the unique IgNAR antibodies could be used to prevent the growth of cancer cells and research into them could lead to the development of new drugs to fight the …
|
Breast Cancer: Sharks’ Antibodies Could Hold Key
Sky News Sharks could provide the key to combating breast cancer. Scientists at Aberdeen University believe that antibodies which help sharks fight off cancerous cells could do the same job in the human body. They are beginning a three-year study to monitor how … |
BBC News |
Shark antibodies ‘may target breast cancer’
BBC News Scientists have been awarded more than £200,000 to examine whether antibodies found only in sharks can be used to help treat breast cancer. The biologists from the University of Aberdeen have been awarded the grant from the Association for … |
BBC News |
Antibodies found in shark blood could help tackle breast cancer
stv.tv A type of antibody found only in the blood of sharks could help tackle breast cancer. It is thought that the unique IgNAR antibodies could be used to prevent the growth of cancer cells. Research into the antibodies could lead to the development of new … Breast Cancer: Sharks’ Antibodies Could Hold KeySky News Shark antibodies ‘may target breast cancer’BBC News Shark antibodies may aid breast cancer fightScotland on Sunday Business Standard all 5 news articles » |